Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype

International Immunology
Brigitte Santner-NananRalph Nanan

Abstract

We and others recently described a method for isolating viable forkhead boxp3 (FoxP3(+)) T regulatory cells (Tregs) by means of the surface phenotype CD4(+)CD127(lo)CD25(+). In this study, we used the new strategy to measure Treg numbers, phenotype and function at different ages. Mean percentages of CD4(+)CD127(lo)CD25(+) Tregs increased only slightly throughout life, from 6.10% in cord blood to 7.22% in PBMC from adults between 20 and 25 years and 7.50% in PBMC from adults over the age of 60. In all age groups, a higher proportion of Tregs had acquired a CD45RA(-) memory phenotype compared with CD4(+)Foxp3(-) conventional T cells. This increase was entirely attributable to increased Tregs with an effector memory phenotype, whereas central memory phenotype cells were comparably represented within the Treg and conventional CD4(+) T-cell populations. Expression of CD95 also differed between Tregs and conventional CD4(+) T cells at all ages. However there was no difference in the suppressive capacity of the different naive and memory Treg subsets. These results suggest that, compared with their conventional CD4(+) T-cell counterparts, Tregs undergo preferential differentiation from a naive to an effector memory phenotype, driven b...Continue Reading

References

Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J J CampbellL Wu
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Baecher-AllanD A Hafler
Jun 17, 2003·Nature Immunology·Benedict SeddonRose Zamoyska
Sep 30, 2003·Journal of Neuroscience Research·Laura TsaknaridisArthur A Vandenbark
Dec 10, 2003·The Journal of Experimental Medicine·Robyn M KondrackLinda M Bradley
Dec 17, 2003·The Journal of Experimental Medicine·JiChu LiSusan L Swain
Mar 23, 2004·Annual Review of Immunology·Federica SallustoAntonio Lanzavecchia
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
Feb 1, 2005·European Journal of Immunology·Tom CupedoHergen Spits
Jun 4, 2005·Clinical and Experimental Immunology·R GreggP A Moss
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Benedikt FritzschingElisabeth Suri-Payer
Jul 12, 2005·The Journal of Clinical Investigation·Danila ValmoriMaha Ayyoub
Oct 8, 2005·Current Opinion in Immunology·Jeffrey A Bluestone, Qizhi Tang
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ruth D FritschPeter E Lipsky
Dec 8, 2005·Blood·Nabila SeddikiBarbara Fazekas de Saint Groth
Apr 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Clare Baecher-AllanDavid A Hafler
Jul 5, 2006·The Journal of Experimental Medicine·Nabila SeddikiBarbara Fazekas de St Groth
Jul 5, 2006·The Journal of Experimental Medicine·Weihong LiuJeffrey A Bluestone
Aug 15, 2006·Immunological Reviews·Jens LohrAbul K Abbas

❮ Previous
Next ❯

Citations

Sep 3, 2010·Immunological Investigations·Saladin SawanEyad Elkord
Nov 28, 2015·Reviews on Environmental Health·Mary Redmayne, Olle Johansson
Oct 22, 2010·Journal of Reproductive Immunology·Ganesa WegienkaChristine Cole Johnson
Nov 15, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Allan R TenorioAlan L Landay
Sep 6, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Francisco J SalgadoMontserrat Nogueira
Oct 20, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrea SteinbornChristof Sohn
May 9, 2012·Current Opinion in Immunology·Jana RaynorClaire A Chougnet
Oct 14, 2014·Frontiers in Microbiology·Jorjoh Ndure, Katie L Flanagan
May 5, 2016·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Anders H KvernelandBirgit Sawitzki
Oct 16, 2015·Revista da Associação Médica Brasileira·Wilson de Melo CruvinelLuis Eduardo Coelho Andrade
Mar 1, 2018·Frontiers in Immunology·Richard DugglebyAurore Saudemont
Jan 6, 2018·Nature Communications·Aurélie DurandBruno Lucas
Apr 13, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Behdad AfzaliGiovanna Lombardi
Jul 7, 2019·Nature Protocols·Akihiro IsozakiKeisuke Goda
Sep 22, 2019·Nature Reviews. Drug Discovery·Leonardo M R FerreiraQizhi Tang
Jul 6, 2017·Clinical and Experimental Immunology·S HayakawaM Kobayashi
Nov 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brigitte Santner-NananRalph Nanan
Sep 8, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hanna GrindebackeAnna Rudin
Feb 18, 2020·Journal of Immunoassay & Immunochemistry·Karima SahmoudiFouad Seghrouchni
Jul 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Celine S LagesClaire Chougnet
Feb 3, 2021·The FEBS Journal·Biaolong DengBin Li
Apr 7, 2019·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mark E RudolphMarcelo B Sztein
Jun 25, 2021·International Immunopharmacology·Alexander Batista-DuharteRafael Solana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.